Compare ResMed Inc. (RMD) vs J M Smucker Co (SJM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs J M Smucker Co — how do they compare? ResMed Inc. trades at $230.05 (market cap $31.89B), while J M Smucker Co trades at $119.83 (market cap $12.76B). The key difference: ResMed Inc. is far larger — about 2.5× J M Smucker Co's market cap, and J M Smucker Co pays the higher dividend (3.75%). Which is the better fit depends on your goals — on Pluang, investors hold ResMed Inc. for 51 Days and J M Smucker Co for 74 Days on average.
| RMD | SJM | |
|---|---|---|
Market Cap | $31.89B | $12.76B |
Volume | 618,314 | 1,300,545 |
Sector | Health | Consumer Staples |
52-Week High | $275.96 | $132.34 |
52-Week Low | $182.82 | $89.53 |
Typical Hold Time | 51 Days | 74 Days |
Enterprise Value | $31.24B | $19.61B |
Dividend Yield | 1.16% | 3.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $226.73, up 0.33% today, with a bullish technical signal from moving averages and a neutral RSI. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $5.15 billion in 2025, with a net income margin of 26.94%, while cash flow from operations reached $1.75 billion. Recent news highlights an upcoming Q1 2027 earnings report and management's focus on 12%-14% EPS growth driven by demand in sleep therapy.
The outlook for RMD is positive, supported by robust fundamentals and analyst consensus, though risks include competitive pressures and ongoing legal investigations. Upside potential exists with a consensus price target of $242.70, representing a 7% increase from current levels, but investors should monitor execution against growth targets and market share dynamics.
SJM trades at $119.41, up 3.0% today, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with a consensus price target of $138.23, though high valuation ratios and recent net losses highlight fundamental challenges. Recent news highlights robust growth in segments like Uncrustables and raised fiscal 2027 guidance, but investor caution persists due to margin pressures and competitive headwinds in the consumer staples sector.
The outlook for SJM is cautiously optimistic, driven by earnings beats and strategic brand strength, but risks include volatile profitability, elevated debt, and sector competition. Upside potential exists if the company sustains revenue growth and improves net margins, aligning with analyst targets, though macroeconomic factors and execution risks could limit near-term gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About J M Smucker Co
J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →
